Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

Date: 11/14/2018 HERCULES, Calif.–A Federal District Court jury yesterday found that 10X Genomics willfully infringed three United States patents owned by the University of Chicago and exclusively licensed to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products (NYSE: BIO and BIOb). In awarding Bio-Rad $23.9 million in damages, the... Read more

10x Genomics Showcases New Solutions at ASHG 2018

Introduces significant advances to its flagship Single Cell Gene Expression Solution   PLEASANTON, CA.—October 16, 2018—10x Genomics, a leader in the genomics field, today announced the commercial availability of new solutions and technology that will significantly impact the future of genomic research by moving toward single cell multi-omics analysis. The new solutions will be showcased... Read more

10x Genomics Acquires Epinomics

Furthers 10x Leadership across Genomics Applications; Brings Inventors of ATAC-seq Technology to 10x PLEASANTON, CA.—August 28, 2018—10x Genomics, a leader in the genomics field, today announced its first acquisition with Epinomics, a pioneer in the growing epigenetics space. The acquisition will give 10x Genomics ATAC-seq technology and fundamental IP to accelerate discoveries and further research in... Read more

10x Genomics Partners with BioLegend and Immudex to Extend Research Applications of Its New Single Cell Feature Barcoding Technology

PLEASANTON, CA.—July 31, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that BioLegend and Immudex will be the first 10x Compatible Partners providing products for its new single cell Feature Barcoding Technology, which was revealed at the 2018 Advances in Genome Biology and Technology meeting in February this year. The resulting product innovations, available at the end of... Read more

10x Genomics Extends their Application Portfolio with the Launch of Single Cell Mouse Immune Profiling Solution

–New solution characterizes single cell gene expression and paired receptor sequences of T- and B-cells in mouse models of disease– PLEASANTON, CA.—June 20, 2018—10x Genomics, a company focused on accelerating discovery, today announced the launch of the Single Cell Mouse Immune Profiling Solution. For the first time, researchers will have the ability to simultaneously and... Read more

10x Genomics Completes $50 Million Series D Financing and $75M Debt Facility

PLEASANTON, CA.—April 26, 2018—10x Genomics, a company focused on accelerating genomic discovery, today announced that it had raised $125 million in funding. The funding included a $50 million Series D financing. It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the... Read more

10x Genomics Expands Offering by Launching New Single Cell Solution Focused on DNA

–Early access researchers will present data at the annual meeting of the American Association for Cancer Research in Chicago this week– PLEASANTON, CA.—April 13, 2018—10x Genomics, a company focused on accelerating genomic discovery, today launched the Chromium Single Cell CNV Solution, which is the first scalable and easy-to-use technology for rapid and massively parallel profiling of... Read more

10x Genomics Becomes a Partner in the CanSeq150 Initiative

–CanSeq150 Initiative will use 10x Genomics’ Chromium de novo Assembly Solution to generate high quality, cost-effective assemblies for new genomes– PLEASANTON, CA.—April 5, 2018—10x Genomics, a company focused on accelerating genomic discovery, announced today a partnership with the CanSeq150 Initiative, a sequencing initiative by Canada’s Genomics Enterprise (CGEn). CanSeq150 aims to sequence 150 new genomes... Read more

10x Genomics Announces New Partnership Programs

–New Certified Service Provider and Compatible Partnership Programs will provide an extended ecosystem of reliable NGS workflow solutions for 10x Genomics’ customers– PLEASANTON, CA.—February 12, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced a global partnership ecosystem to accelerate customer adoption of 10x Genomics’ sequencing applications through the Certified Service Provider... Read more

10x Genomics joins EMBL’s Corporate Partnership Program

–Joining forces for single-cell research excellence– PLEASANTON, CA.—February 21, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today announced that it has joined the Corporate Partnership Program of the European Molecular Biology Laboratory (EMBL), one of the world’s leading research institutions. “As a leader in single cell genomics, 10x Genomics is investing in... Read more